GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sinopharm Group Co Ltd (HKSE:01099) » Definitions » Effective Interest Rate on Debt %

Sinopharm Group Co (HKSE:01099) Effective Interest Rate on Debt % : 3.09% (As of Jun. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Sinopharm Group Co Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Sinopharm Group Co's annualized positive value of Interest Expense for the quarter that ended in Jun. 2024 was HK$2,929 Mil. Sinopharm Group Co's average total debt for the quarter that ended in Jun. 2024 was HK$94,746 Mil. Therefore, Sinopharm Group Co's annualized Effective Interest Rate on Debt % for the quarter that ended in Jun. 2024 was 3.09%.

Sinopharm Group Co Effective Interest Rate on Debt % Historical Data

The historical data trend for Sinopharm Group Co's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinopharm Group Co Effective Interest Rate on Debt % Chart

Sinopharm Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Effective Interest Rate on Debt %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.18 5.69 5.58 4.87 4.08

Sinopharm Group Co Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.42 4.13 4.01 3.07 3.09

Competitive Comparison of Sinopharm Group Co's Effective Interest Rate on Debt %

For the Medical Distribution subindustry, Sinopharm Group Co's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sinopharm Group Co's Effective Interest Rate on Debt % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sinopharm Group Co's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Sinopharm Group Co's Effective Interest Rate on Debt % falls into.


Sinopharm Group Co Effective Interest Rate on Debt % Calculation

Sinopharm Group Co's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2023 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Dec. 2022 )+Total Debt  (A: Dec. 2023 ))/ count )
=-1  *  -3233.852/( (77712.385+80701.032)/ 2 )
=-1  *  -3233.852/79206.7085
=4.08 %

where

Total Debt  (A: Dec. 2022 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=16702.694 + 61009.691
=77712.385

Total Debt  (A: Dec. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=18873.021 + 61828.011
=80701.032

Sinopharm Group Co's annualized Effective Interest Rate on Debt % for the quarter that ended in Jun. 2024 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Dec. 2023 )+Total Debt  (Q: Jun. 2024 ))/ count )
=-1  *  -2929.11/( (80701.032+108790.343)/ 2 )
=-1  *  -2929.11/94745.6875
=3.09 %

where

Total Debt  (Q: Dec. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=18873.021 + 61828.011
=80701.032

Total Debt  (Q: Jun. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=21106.349 + 87683.994
=108790.343

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is two times the semi-annual (Jun. 2024) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

Sinopharm Group Co  (HKSE:01099) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Sinopharm Group Co Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Sinopharm Group Co's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinopharm Group Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sinopharm Group Co Ltd (HKSE:01099) » Definitions » Effective Interest Rate on Debt %
Comparable Companies
HKSE:00314 HKSE:01931 HKSE:09955 HKSE:02289 HKSE:08223 HKSE:06833 HKSE:00718 HKSE:00673 HKSE:08372 HKSE:00401 MCK COR CAH ASX:SIG HSIC SHSE:601607 MIL:AMP SHSE:600332 XSWX:GALE NZSE:EBO
Traded in Other Exchanges
SHTDY:USA SHTDF:USA X2S:Germany
Address
No. 385, East Longhua Road, Sinopharm Group Building, Huangpu District, Shanghai, CHN, 200023
Website
http://www.sinopharmgroup.com.cn
Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm's largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2023. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm's total revenue. Sinopharm's downstream customers range from hospitals and other health services institutions to end-customers.
Executives
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Lazard Asset Management Llc 2102 Investment manager
Zhong Xin Zheng Quan Yun Fan Dan Yi Zi Chan Guan Li Ji Hua 2501 Other
Zhong Xin Zheng Quan Zi Chan Guan Li You Xian Gong Si 2102 Investment manager
Citic Securities Company Limited 2201 Interest of corporation controlled by you
Citigroup Inc. 2502 Approved lending agent
Fmr Llc 2201 Interest of corporation controlled by you
Blackrock, Inc. 2201 Interest of corporation controlled by you

Sinopharm Group Co Headlines

No Headlines